Neurosciences

Luminopia closed an oversubscribed $16 million Series A financing round, which will be used to support the commercial rollout of the Luminopia software-based therapeutic for amblyopia later this year, according to a press release.

SAN FRANCISCO — Today’s psychotherapy has evolved to incorporate psychobiology and neuroscience, David J. Hellerstein, MD, says in this Healio video at the American Psychiatric Association Annual Meeting.

A patient’s duration of Parkinson’s disease can affect visual field sensitivity, according to a poster presented at the North American Neuro-Ophthalmology Society meeting.

A study investigating nonarteritic ischemic optic neuropathy in the U.S. found notable prevalence in white men and Black men and women and frequent association with diabetes and high cholesterol levels.

An accelerated “papilledema protocol” in the emergency department, including prompt neuro-ophthalmology and neurology consults, blood pressure monitoring, MRI, MRV and lumbar puncture, could save patients’ vision and lives.

During a 2-year peri-COVID period, more cases of acute nonarteritic anterior ischemic optic neuropathy were seen at a tertiary care center than during a previous 2-year period.

The Lieber Institute for Brain Development received a $1 million grant from the Chan Zuckerberg Initiative to fund efforts to promote racial equity in neuroscience, according to an institute press release.

The Pershing Square Foundation announced the launch of the Maximizing Innovation in Neuroscience Discover prize to establish a community of multidisciplinary investigators who can improve understanding of the brain and cognition.

Gate Neurosciences is developing a new portfolio of next-generation therapeutics to treat synaptic dysfunction in patients with central nervous system disorders, the company announced in a press release.

WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2022, Andrew G. Lee, MD, discusses the monocular temporal crescent and how it can be identified.